NIDANNSENIDAN LABS AND HEALTH LTDMinimalNeutral
Announced Mon, 5 Oct, 2026 · 15:58 IST

Nidan Labs: Corporate Governance report not applicable for Q2 FY27

NIDAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.6%Reaction day
₹12.60
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+2.3% vs market

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+3.6+1.3+2.3
Next day
+3.2+1.1+2.1
2d
+7.1-1.7+8.9
3d
+5.2-1.5+6.6
4d
+3.2-0.6+3.8
5d
+7.1-0.4+7.6
1w
+6.3-1.4+7.7
15d
———
1m
———
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nidan Labs has informed the NSE that the quarterly Corporate Governance compliance report under SEBI Regulation 27 is not applicable to the company for the quarter ended 30 September 2026. The company is listed on the SME platform of NSE, and under Regulation 15 of SEBI LODR rules, SME-listed companies are exempt from this filing requirement. Signed by Executive Director and CFO Tejal Anil Jayakar.

Likely market impact

Routine compliance filing with no material impact on shareholders or stock price. No action required from investors.